• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.53% Nasdaq Up0.11%

    IsoRay, Inc. (ISR)

    -NYSE MKT
    1.43 Down 0.03(2.05%) 4:02PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    IsoRay, Inc.
    350 Hills Street
    Suite 106
    Richland, WA 99354
    United States - Map
    Phone: 509-375-1202
    Website: http://www.isoray.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:37

    Business Summary 

    IsoRay, Inc develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is headquartered in Richland, Washington.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IsoRay, Inc.

    Key Executives 
     PayExercised
    Mr. Dwight Babcock , 67
    Chairman and Chief Exec. Officer
    334.00K0.00
    Mr. Brien L. Ragle , 46
    Chief Financial Officer
    117.00K0.00
    Mr. William Cavanagh III, 49
    VP of R&D and VP of R&D - Isoray Medical Inc
    154.00K0.00
    Krista Cline ,
    Corp. Sec.
    N/AN/A
    Mr. Lance A. Bray , 87
    Chief Chemist of Isoray Medical Inc
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders